The future of combination strategies lies in precision medicine. Advances in genomics and molecular biology are enabling more personalized approaches, tailoring treatments to individual patients based on their genetic profiles. Additionally, the development of new drugs and therapeutic modalities, such as CAR-T cell therapy and oncolytic viruses, promises to expand the arsenal of combination strategies.
